We are live on
!
Find out more
Viking Therapeutics
VKTX
VKTX
18 hedge funds and large institutions have $3.85M invested in Viking Therapeutics in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
128% more capital invested
Capital invested by funds: $1.69M → $3.85M (+$2.16M)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more funds holding
Funds holding: 12 → 18 (+6)
1.63% more ownership
Funds ownership: 5.67% → 7.3% (+1.6%)
Holders
18
Holders Change
+6
Holders Change %
+50%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Ascend Capital
Orinda,
California
|
+$554K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$329K |
| 3 |
Renaissance Technologies
New York
|
+$118K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$64.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$58.2K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$525K |
| 2 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$11.4K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2K |
